Fundraising Fox
PhotonPharma
Fort Collins, US · Founded 2018 · Colorado corporation · 1 known investors
Find your way into PhotonPharma
Sign up to see every warm intro you have to PhotonPharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the PhotonPharma team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PhotonPharma develops riboflavin and UV-based treatment technology (disposables and equipment) optimized for cancer immunotherapy and vaccine production. The company works with Colorado State University's School of Biomedical Engineering and external consultants to advance its immunotherapy platform.
Founders & leadership
MC
Milton ChangNamed on SEC filing
AR
Alan RudolphNamed on SEC filing
WB
Wolfgang BaikerNamed on SEC filing
GG
Gary GordonNamed on SEC filing
TO
Terry OpgenorthNamed on SEC filing
RG
Raymond GoodrichCo-founder
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 2 rounds · 2022–2024
▶$350KraisedMay 2024 · 2 investors · Other TechnologyRule 506(b)
▶$350KraisedMay 2024 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Terry OpgenorthDirector
- Wolfgang BaikerDirector
- Gary GordonDirector
- Raymond GoodrichDirector
- Alan RudolphExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $350K
- First sale
- May 2024
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$2.9MraisedAug 2023 · 8 investors · BiotechnologyRule 506(b)
▶$2.9MraisedAug 2023 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Milton ChangDirector
- Alan RudolphExecutive Officer, Director
- Wolfgang BaikerDirector
- Gary GordonDirector
- Terry OpgenorthDirector
- Raymond GoodrichDirector
- Offering amount
- $3.9M
- Amount sold
- $2.9M
- First sale
- Jan 2022
- Incorporated
- Corporation, Colorado, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
LyellLyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
RadiuspharmRadius is a pharmaceutical company that provides funding through Investigator Initiated Study grants and independent Medical Education grants supporting clinical research and continuing medical education for healthcare professionals in therapeutic areas related to its products.
Companies working in the same space as PhotonPharma.
In the news
Frequently asked questions
- What does PhotonPharma do?
- PhotonPharma develops riboflavin and UV-based treatment technology (disposables and equipment) optimized for cancer immunotherapy and vaccine production. The company works with Colorado State University's School of Biomedical Engineering and external consultants to advance its immunotherapy platform.
- Who are PhotonPharma's investors?
- PhotonPharma's investors include Colorado BioScience Association.
- How much funding has PhotonPharma raised?
- PhotonPharma has disclosed $3.3M raised across 2 rounds.
- Where is PhotonPharma headquartered?
- PhotonPharma is headquartered in Fort Collins, US.